Pharmacogenetic Testing for Predicting Methylphenidate Treatment Outcomes in Childhood Attention Deficit Hyperactivity Disorder in Turkey: Focus on Carboxylesterase 1, Latrophilin-3, and Catechol-O-Methyltransferase
Am J Med Genet B Neuropsychiatr Genet. 2025 Jan 27:e33024. doi: 10.1002/ajmg.b.33024. Online ahead of print. ABSTRACT Pharmacogenetic studies involving Carboxylesterase 1 (CES1), Latrophilin-3 (LPHN3), …